Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
 |
afrol News - February 6, 2009
Human Rights Watch in December last year accused the Kenyan government of neglecting children in the roll out of life saving drugs, saying half of all children born with HIV will die before their second birthdays. However, the government denied the reports.
HRW said as Kenya's National Aids Control Council (NACC) prepares a new five-year strategic plan, it should not leave thousands of children who need life saving drugs in the country.
HRW Senior Researcher in the Children's Rights Division, Juliane Kippenberg said it is critical for Kenya to recognise that basic human rights issues, should be incorporated in the HIV strategy, policy, and programming.
"HIV/AIDS strategies in Kenya too often focus only on medical care itself. Steps to promote and protect human rights need to take place in tandem with steps that improve medical care if the strategy is going to be successful," she said.
About half of adult Kenyans who need anti-retroviral treatment are receiving it, compared to an estimated one-third of children who need such treatment, the group has observed.
"Many children are falling through the cracks when it comes to testing and treatment. Health facilities should offer testing to all children below the age of 5, and all children whose mothers are HIV-positive or who have died of the disease," Ms Kippenberg said.
Anti-retroviral treatment for children is often offered only at central health facilities, and not at local ones, making transportation costs a significant barrier to access. Frequently, children are also not taken for testing by their caregivers because of the stigma attached to the illness, misinformation, neglect, or lack of resources, according to the right's organisation.
Human Rights Watch appealed to both the Kenyan government and international donor agencies to strengthen health and child-protection systems to boost access to treatment for children.
090206
AO090201
Copyright © 2009 - afrol News. All rights reserved. Reproducing or buying afrol News' articles.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .